Mesoblast completes $75 million capital raising
03 Oct 2019 - Leader in cellular medicines for inflammatory diseases, Mesoblast (ASX:MSB) has successfully completed a $75 million capital raising.
03 Oct 2019 - Leader in cellular medicines for inflammatory diseases, Mesoblast (ASX:MSB) has successfully completed a $75 million capital raising.
03 Oct 2019 - Telstra (ASX:TLS) has appointed a new Group Executive of Product & Technology - Kim Krogh Andersen will replace Christian von Reventlow.
03 Oct 2019 - Clean Seas Seafood (ASX:CSS) has to delay the opening of its new farm at Fitzgerald Bay, near Whyalla in Queensland.
03 Oct 2019 - Senex Energy (ASX:SXY) has completed the Project Atlas natural gas pipeline.
03 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) has entered into a conditional purchase agreement with technology giant Eckert & Ziegler to acquire a radiopharmaceutical production facility in Belgium.
03 Oct 2019 - Following negative leads from US markets, the ASX looks set to open lower this morning. The Dow plunged more than 450 points as Wall Street continues its rough start to the fourth quarter. Treasuries climbed. Engineering company SRG Global (ASX:SRG) says Enzo Gullotti has resigned as Executive Director from the company.
02 Oct 2019 - It has been a disappointing day of trade for the ASX. After opening in the red the local bourse continued to lose momentum to close 1.5% lower. It was good news for Mayne Pharma (ASX:MYX) though as their shares shot up today after entering into an agreement with Mithra Pharmaceuticals to commercialise a combined oral contraceptive in the US. Blue Sky Alternatives Access Fund (ASX:BAF) has settled a deal to sell its interests in the...
02 Oct 2019 - The ASX opened lower following soft leads from Wall Street and is now tracking 1.3% lower at noon. The markets dropped on poor manufacturing result from the US and weak manufacturing data from Europe. ResApp Health (ASX:RAP) reports that ResAppDx-EU, the world’s first smartphone-based diagnostic test for acute paediatric respiratory disease, has received Australian Therapeutics Goods Administration (TGA) approval.
02 Oct 2019 - The National Australia Bank (ASX:NAB) today announced additional charges of $1.18 billion after tax relating to increased provisions for customer-related remediation.
02 Oct 2019 - Mineral Resources (ASX:MIN) has notified Hexagon Resources (ASX:HXG) that they are withdrawing from the McIntosh Joint Venture (MJV) at the end of the month.